Two previous integrated analysis studies reported that RBM26-AS1 acts as a ceRNA in high-glucose-induced human retinal endothelial cells (Cao et al., 2020) and pancreatic cancer (Liu et al., 2020). This evidence concerns the gene RBM26 and familial pancreatic carcinoma.